WHO ICTRP trial
Randomization of Sodium Alginate and Mosapride Citrate for Patients with…
JPRN-UMIN000000772 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000000772 |
|---|---|
| Public title | Randomization of Sodium Alginate and Mosapride Citrate for Patients with Gastroesophageal Reflux Disease (GERD) Following Distal Gastrectomy with Billroth I Reconstruction - A Multicenter Comparative Study |
| Scientific title | Randomization of Sodium Alginate and Mosapride Citrate for Patients with Gastroesophageal Reflux Disease (GERD) Following Distal Gastrectomy with Billroth I Reconstruction - A Multicenter Comparative Study - Randomization of Sodium Alginate and Mosapride Citrate for Patients with Gastroesophageal… |
| Primary sponsor | Kyosei Pharmaceutical Co., Ltd. |
| Secondary sponsors | Kaigen Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Gastroesophageal Reflux Disease Following Distal Gastrectomy with Billroth I Reconstruction |
| Interventions | Sodium alginate group: 20 mL of Alloid G administered for 8 weeks four times a day (q.i.d.) after meals and before bed. Mosapride citrate group: 5 mg of Gasmotin tablet administered for 8 weeks three times a day (t.i.d.) after meals. |
| Registration date | Jul 18, 2007 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: